David Bassett's practice concentrates on intellectual property litigation, particularly on biotechnology, pharmaceutical and Hatch-Waxman patent disputes. He also represents clients in a wide variety of other business disputes, including breach of contract, Lanham Act and Internet-related claims. Mr. Bassett's intellectual property litigation clients have included Forest (Allergan), Gilead Sciences, Foundation Medicine, Precision BioSciences, Biogen, Procter & Gamble, Calgene, Cephalon, Kurzweil Music, RSA Security, Braintree Laboratories, and many others in the life sciences industry and beyond. His practice has covered all facets of litigation, including discovery, settlement, alternative dispute resolution, trials and appeals. Mr. Bassett has been lead trial lawyer in more than a dozen patent trials (both bench and jury), and has appeared before the Courts of Appeals for the First and Federal Circuits.
Executive Committee of the New York State Bar Association, Intellectual Property Law Section
Member, American Bar Association
Member, Massachusetts Bar Association
Harvard Law School, J.D. cum laude (1987)
Indiana University, B.A. with honors (1984)